Musculoskeletal pain
Conditions
Interventions
Exposure group:Yunnan White Medicine Ointment
The non-exposure group:conventional therapy
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1: (1) Age = 18 years, gender; 2: (2) Meet the diagnostic criteria for musculoskeletal pain, including osteoarthritis, low back pain (including nonspecific low back pain, spine-related low back pain), cervical spondylosis, rotator cuff injury, periarthritis of the shoulder, lateral epicondylitis of the humerus (tennis elbow), medial epicondylitis of the humerus (golfer's elbow), and chronic pain after musculoskeletal injury; 3: (3) Persistent or intermittent pain = 30 days, with no indication for surgery; 4: (4) Volunteers who sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1: (1) Generalized pain, cancer-related pain, neuropathic pain (such as herpes zoster and postherpetic neuralgia, diabetic neuropathy, complex regional pain syndrome, postoperative pain syndrome, phantom limb pain, central pain), vascular pain (such as erythromelalgia, acrocyanosis, atherosclerotic occlusive disease, thromboangiitis obliterans, Raynaud's disease, thrombophlebitis, livedo reticularis, giant cell arteritis, etc.), and rheumatic immune diseases (such as rheumatoid arthritis, ankylosing spondylitis, etc.). 2: (2) History of neurological and psychiatric diseases, such as schizophrenia, depression, epilepsy, or acute episodes of epilepsy, or long-term use of psychiatric medications. 3: (3) Concurrent malignant tumors, severe primary cardiovascular diseases (cardiovascular diseases with significant clinical symptoms and potential severe complications), severe liver or kidney diseases, or other serious conditions affecting survival. 4: (4) Individuals with damaged or abnormal skin at the application site (such as rashes, eczema, post-surgery, etc.), or individuals with allergic skin conditions. 5: (5) History of allergy to the patch matrix or investigational drug, or allergic constitution (allergic to two or more substances). 6: (6) Pregnant women, breastfeeding women, or those with recent plans for pregnancy. 7: (7) Participants who have been involved in other interventional clinical trials within the past three months. 8: (8) Individuals deemed unsuitable for participation in the study by the investigator, such as those with physical or work conditions that may exacerbate pain.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EuroQoL Five-Dimensional Questionnaire;Pain NRS Score;Anxiety and Depression Scale; | — |
Countries
China
Contacts
Public ContactXiao Hong
West China Hospital of Sichuan University
Outcome results
None listed